Fuzhengjiedu formula exerts protective effect against LPS-induced acute lung injury via gut-lung axis

6-Gingerol via overexpression of miR-322-5p impede lipopolysaccharide-caused inflammatory response in RAW264.7 cells

(2023) Talha Umar et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Liquiritin exhibits anti-acute lung injury activities through suppressing the JNK/Nur77/c-Jun pathway

(2023) Hongling Zhou et al.   Chinese Medicine

Methionine Restriction Prevents Lipopolysaccharide-Induced Acute Lung Injury via Modulating CSE/H2S Pathway

(2022) Jiaxiang Duan et al.   Nutrients

Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies

(2022) Yilun Wang et al.   EBioMedicine

Analysis of gastric microbiota and Helicobacter pylori infection in gastroesophageal reflux disease

(2022) Titong Sugihartono et al.   Gut Pathogens

The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes

(2021) Valentin Sencio et al.   Mucosal Immunology

The microbiota in pneumonia: From protection to predisposition

(2021) Charlotte Thibeault et al.   Science Translational Medicine

Macrophages in Lung Injury, Repair, and Fibrosis

(2021) Peiyong Cheng et al.   Cells

Regulatory Effects of Quercetin on M1/M2 Macrophage Polarization and Oxidative/Antioxidative Balance

(2021) Cheng-Fang Tsai et al.   Nutrients

Gut-Lung Crosstalk in Sepsis-Induced Acute Lung Injury

(2021) Xin Zhou et al.   Frontiers in Microbiology

Host Factors Affect the Gut Microbiome More Significantly than Diet Shift

(2021) Enkhchimeg Lkhagva et al.   Microorganisms

The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks

(2020) Raphaël Enaud et al.   Frontiers in Cellular and Infection Microbiology

The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases

(2020) Dapeng Zhang et al.   Frontiers in Microbiology

Molecular Dynamics of Lipopolysaccharide-Induced Lung Injury in Rodents

(2020) Hannes Domscheit et al.   Frontiers in Physiology

Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury

(2020) Zhenhong Liu et al.   CELL CALCIUM

Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome

(2020) Xuxin Chen et al.   INFLAMMATION RESEARCH

Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis

(2020) Kent A. Willis et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway

(2020) Jia Tang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Effect and safety of Chinese herbal medicine granules in patients with severe coronavirus disease 2019 in Wuhan, China: a retrospective, single-center study with propensity score matching

(2020) Yuanyuan Wang et al.   PHYTOMEDICINE

Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2

(2019) Jinyan Ye et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization

(2019) Chao Song et al.   EXPERIMENTAL CELL RESEARCH

Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4–MyD88–NF-κB signaling pathway

(2019) Naigang Wang et al.   ARCHIVES OF PHARMACAL RESEARCH

The Intestinal Epithelium: Central Coordinator of Mucosal Immunity

(2018) Joannie M. Allaire et al.   TRENDS IN IMMUNOLOGY

UHPLC-Q-TOF MS-Based Metabolic Analysis for the Therapeutic Efficacy of “Xuebijing Injection” against Sepsis-Induced Acute Lung Injury

(2018) Xuan Shi et al.   Evidence-based Complementary and Alternative Medicine

Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model

(2018) Wen-Jing Zhong et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A Novel Forming Method of Traditional Chinese Medicine Dispersible Tablets to Achieve Rapid Disintegration Based on the Powder Modification Principle

(2018) Pan Li et al.   Scientific Reports

Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes

(2017) Thomas Clavel et al.   IMMUNOLOGICAL REVIEWS

Iron Reduces M1 Macrophage Polarization in RAW264.7 Macrophages Associated with Inhibition of STAT1

(2017) Zhen-Shun Gan et al.   MEDIATORS OF INFLAMMATION

Emerging pathogenic links between microbiota and the gut–lung axis

(2016) Kurtis F. Budden et al.   NATURE REVIEWS MICROBIOLOGY

Therapeutic targeting of acute lung injury and acute respiratory distress syndrome

(2016) Theodore J. Standiford et al.   Translational Research

Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release

(2015) Xin-xin Liu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology

(2014) Amanda Piper et al.   RESPIROLOGY

Data, information, knowledge and principle: back to metabolism in KEGG

(2013) Minoru Kanehisa et al.   NUCLEIC ACIDS RESEARCH

Pulmonary-intestinal cross-talk in mucosal inflammatory disease

(2011) S Keely et al.   Mucosal Immunology

Metagenomic biomarker discovery and explanation

(2011) Nicola Segata et al.   GENOME BIOLOGY

Activation of lung macrophage subpopulations in experimental acute pancreatitis

(2010) Sabrina Gea-Sorlí et al.   JOURNAL OF PATHOLOGY

Animal models of acute lung injury

(2008) Gustavo Matute-Bello et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Inhibition of lipopolysaccharide-mediated rat alveolar macrophage activation in vitro by antiflammin-1

(2008) Jianzhong Han et al.   CELL BIOLOGY INTERNATIONAL